Home / Going-concern warnings / Prime Medicine, Inc.
Filed 2025-05-08 路 Form 10-Q 路 Accession 0001628280-25-023486 micro
Price before filing: $1.42 (2025-05-07 close, split/dividend-adjusted)
Market cap at flag: $170.5M (2025-05-08) 路 Latest: $615.0M (2026-10-16)
| Window | PRME | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +17.6% | +6.9% | +10.7% | 2025-06-09 |
| 90 days | +186.6% | +13.1% | +173.5% | 2025-08-06 |
| 180 days | +202.8% | +21.0% | +181.8% | 2025-11-04 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: 3 insiders bought $284K (3 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-05-08: red flag filed | |||||||
| 2025-05-20 | Brudnick Richard Chief Business Officer | Purchase | 20,000 | $1.19 | $24K | no | Form 4 |
| 2025-05-21 | LEE ANN L. Chief Technical Officer | Purchase | 100,000 | $1.13 | $113K | no | Form 4 |
| 2025-05-21 | Reine Allan Chief Executive Officer, Director | Purchase | 125,000 | $1.18 | $147K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-02-07 to 2025-06-07. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"Because certain elements of management's plans to mitigate the conditions that raised substantial doubt about the Company's ability to continue as a going concern are outside of the Company's control, including the ability to raise capital through an equity or other financing, those elements cannot be considered probable according to ASC 205-40, and therefore cannot be considered in the evaluation of mitigating..."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.